JP Morgan Maintains Overweight on Immunocore Holdings, Lowers Price Target to $50
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
JP Morgan analyst Jessica Fye maintains Immunocore Holdings (NASDAQ:IMCR) with a Overweight and lowers the price target from $54 to $50.
JP Morgan analyst Jessica Fye maintains Immunocore Holdings (NASDAQ:IMCR) with a Overweight and lowers the price target from $54 to $50.